Century Therapeutics (IPSC) Shares Outstanding (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Shares Outstanding data on file, last reported at $180.1 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $180.1 million, up 109.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.1 million (up 109.07% YoY), and the FY2025 annual result was $87.5 million, up 1.96% from the prior year.
• Shares Outstanding climbed to $180.1 million in Q1 2026 per IPSC's latest filing, from $87.5 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $180.1 million in Q1 2026 and troughed at $57.6 million in Q1 2022.
• A 5-year average of $77.5 million and a median of $64.8 million in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding soared 631.48% in 2022, then advanced 1.96% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $58.5 million in 2022, then grew by 3.18% to $60.3 million in 2023, then jumped by 42.26% to $85.8 million in 2024, then gained by 1.96% to $87.5 million in 2025, then surged by 105.79% to $180.1 million in 2026.
• Business Quant data shows IPSC's Shares Outstanding at $180.1 million in Q1 2026, $87.5 million in Q4 2025, and $86.5 million in Q3 2025.